Feasibility study of catheter-directed thrombolysis with recombinant staphylokinase in deep venous thrombosis

Thrombosis and Haemostasis

Volumn 79, Issue 3, 1998, Pages 517-519

  Heymans, Stephane ^a   Verhaeghe, Raymond ^b   Stockx, Luc ^b   Collen, Désiré ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN; STAPHYLOKINASE;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CATHETER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; DRUG INFUSION; EPISTAXIS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEMATOMA; HUMAN; MALE; PRIORITY JOURNAL; STENT;

EID: 0031936527     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614936     Document Type: Article

References (18)

1. ten Cate JW, Koopman MM, Prins MH, Buller HR. Treatment of venous thromboembolism. Thromb Haemost 1995; 74: 197-203.
2. Francis CW, Marder VJ. Fibrinolytic therapy for venous thrombosis. Prog Cardiovasc Dis 1991; 34: 193-204.
3. Comerota AJ, Aldridge SC. Thrombolytic therapy for deep venous thrombosis: a clinical review. Can J Surg 1993; 36: 359-64.
4. Goldhaber SZ. Venous thrombosis: prevention, treatment, and relationship to paradoxical embolization. Cardiol Clin 1994; 12: 505-16.
5. Goldhaber SZ, Buring JE, Lipnick RJ, Hennekens CH. Pooled analysis of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984; 76: 393-7.
6. Verstraete M. Thrombolytic therapy of non-cardiac disorders. Baillières Clin Haematol 1995; 8: 413-24.
7. Verhaeghe R, Stockx L, Lacroix H, Vermylen J, Baert AL. Catheter-directed lysis of iliofemoral vein thrombosis with use of rt-PA. Eur Radiol 1997; 7: 996-1001.
8. Semba CP, Dake MD. Ileofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology 1994; 191; 487-94.
9. Comerota AJ, Aldridge SC, Cohen G, Ball DS, Pliskin M, White JV. A strategy of aggressive regional therapy for acute ileofemoral venous thrombosis with contemporary venous thromboectomy or catheter-directed thrombolysis. J Vasc Surg 1994; 20: 244-54.
10. Collen D, Lijnen H. Staphylokinase, a fibrin specific plasminogen activator with therapeutic potential? Blood 1994; 84: 680-6.
11. Collen D, Van de Werf F. Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardeal infarction. Circulation 1993; 87: 1850-3.
12. Vanderschueren S, Barrios L, Kerdsinchai P, Van den Heuvel P, Hermans L, Vrolix M, De Man F, Benit E, Muyldermans L, Collen D, Van de Werf F. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. Circulation 1995; 92: 2044-9.
13. Vanderschueren S, Stockx L, Wilms G, Lacroix H, Verhaeghe R, Vermylen J, Collen D. Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinase. Circulation 1995; 92: 2050-7.
14. Schlott B, Hartmann M, Gührs KH, Birch-Hirschfeid E, Pohl HD, Vanderschueren S, Van de Werf F, Michoel A, Collen D, Behnke D. High yield production and purification of recombinant staphylokinase for thrombolytic therapy. Biotechnology NY 1994; 12: 185-9.
15. Smitz Rode T, Vorwerk D, Schurmann K, Gunther RW. Experimental impeller fragmentation of iliocaval thrombosis under tulip filter protection: preliminary results. Cardiovasc Interv Radiol 1996; 19: 260-4.
16. O'Meara J, McNutt RA, Evans AT. A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. N Engl J Med 1994; 330: 1864-9.
17. Goldhaber SZ, Meyerovitz MF, Green D, Kim H et al. Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis. Am J Med 1990; 88: 235-40.
18. Verhaeghe R, Besse P, Bounameaux H, Marbet GA. Multicenter pilot study of the efficacy and safety of systemic rt-PA administration in the treatment of deep vein thrombosis of the lower extremities and/or pelvis. Thromb Res 1989; 55: 5-11.